Fortress Biotech, Inc.
FBIO
$2.72
$0.010.37%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 196.58M | 255.84M | 79.38M | 86.22M | 74.39M |
| Total Receivables | 36.75M | 25.51M | 29.94M | 18.13M | 16.20M |
| Inventory | 8.16M | 9.29M | 9.62M | 11.82M | 12.85M |
| Prepaid Expenses | 4.02M | 4.84M | 4.90M | 2.34M | 6.96M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 245.51M | 295.48M | 123.84M | 118.50M | 110.40M |
|
|
|||||
| Total Current Assets | 245.51M | 295.48M | 123.84M | 118.50M | 110.40M |
| Net Property, Plant & Equipment | 13.77M | 14.25M | 14.82M | 14.93M | 15.52M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 25.51M | 26.48M | 27.61M | 28.67M | 29.73M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.48M | 1.96M | 1.62M | 19.30M | 4.24M |
| Total Assets | 316.72M | 356.87M | 185.55M | 181.41M | 159.90M |
|
|
|||||
| Total Accounts Payable | 11.86M | 14.14M | 14.24M | 18.77M | 20.19M |
| Total Accrued Expenses | 34.54M | 35.34M | 30.71M | 23.99M | 25.89M |
| Short-term Debt | -- | 2.50M | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.25M | 2.22M | 2.13M | 7.75M | 5.89M |
| Total Finance Division Other Current Liabilities | 8.38M | 49.19M | 2.67M | 3.55M | 5.55M |
| Total Other Current Liabilities | 8.38M | 49.19M | 2.67M | 3.55M | 5.55M |
| Total Current Liabilities | 62.02M | 103.39M | 49.74M | 54.07M | 57.52M |
|
|
|||||
| Total Current Liabilities | 62.02M | 103.39M | 49.74M | 54.07M | 57.52M |
| Long-Term Debt | 34.60M | 36.88M | 52.42M | 47.77M | 50.03M |
| Short-term Debt | -- | 2.50M | -- | -- | -- |
| Capital Leases | 11.47M | 12.03M | 12.67M | 12.77M | 13.30M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.54M | 2.20M | 8.53M | 1.62M | 1.66M |
| Total Liabilities | 110.63M | 154.50M | 123.37M | 116.22M | 122.51M |
|
|
|||||
| Common Stock & APIC | 788.28M | 785.88M | 783.92M | 785.97M | 779.89M |
| Retained Earnings | -624.15M | -623.68M | -734.05M | -730.12M | -735.97M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 164.14M | 162.21M | 49.87M | 55.86M | 43.92M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
|
|
|||||
| Total Common Equity | 164.14M | 162.21M | 49.87M | 55.86M | 43.92M |
| Total Preferred Equity | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
| Total Minority Interest | 41.95M | 40.17M | 12.31M | 9.32M | -6.54M |
| Total Equity | 206.09M | 202.37M | 62.18M | 65.19M | 37.38M |
|
|
|||||